Sensitivity of HIV Type 1 Primary Isolates to Human Anti-CD40 Antibody-Mediated Suppression Is Related to Coreceptor Use
- 1 March 2008
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 24 (3) , 447-452
- https://doi.org/10.1089/aid.2007.0216
Abstract
The effect of CD40 ligation on infection by HIV-1 primary isolates with different R5 phenotypes was evaluated with a novel set of anti-CD40 monoclonal antibodies originating from a human phage display library. Five human monoclonal anti-CD40 antibodies of IgG1 subtype characterized by the ability to activate B cells via CD40 were tested for induction of the CC-chemokines RANTES and MIP-1α and inhibition of HIV-1 replication in primary monocyte-derived macrophages (MDM). All activating anti-CD40 antibodies were able to induce CC-chemokines in MDM. We chose the most potent antibody, clone B44, for further experiments. This antibody had a suppressive effect on HIV-1 isolates of the R5 phenotype with limited use of CCR5/CXCR4 chimeric receptors. In comparison, HIV-1 isolates with broader use of CCR5/CXCR4 chimeric receptors or with CXCR4 use were less sensitive to anti-CD40-induced suppression. The results indicate that HIV-1 replication is inhibited by human anti-CD40 monoclonal antibodies through the mechanism of CC-chemokine induction. This effect is thus restricted to HIV-1 isolates sensitive to inhibition by CC-chemokines.Keywords
This publication has 32 references indexed in Scilit:
- Coevolution of RANTES Sensitivity and Mode of CCR5 Receptor Use by Human Immunodeficiency Virus Type 1 of the R5 PhenotypeJournal of Virology, 2004
- CXCR4‐Tropic HIV‐1 Suppresses Replication of CCR5‐Tropic HIV‐1 in Human Lymphoid Tissue by Selective Induction of CC‐ChemokinesThe Journal of Infectious Diseases, 2004
- Molecular mapping of epitopes for interaction of HIV-1 as well as natural ligands with the chemokine receptors, CCR5 and CXCR4AIDS, 2003
- HIV biological variability unveiledAIDS, 2003
- Increased CD4 and CCR5 Expression and Human Immunodeficiency Virus Type 1 Entry in CD40 Ligand–Stimulated MacrophagesThe Journal of Infectious Diseases, 2002
- CD154 and Type‐1 Cytokine Response: From Hyper IgM Syndrometo Human Immunodeficiency Virus InfectionThe Journal of Infectious Diseases, 2002
- CD40-Activated Macrophages Become Highly Susceptible to X4 Strains of Human Immunodeficiency Virus Type 1AIDS Research and Human Retroviruses, 2002
- SOLUBLE CD40 LIGAND INDUCES β-CHEMOKINE PRODUCTION BY MACROPHAGES AND RESISTANCE TO HIV-1 ENTRYCytokine, 2000
- What is the real role of CD40 in cancer immunotherapy?Published by Elsevier ,1999
- CD40 ligation counteracts Fas-induced apoptosis of human dendritic cellsInternational Immunology, 1997